Robert Regedanz

This inventor holds 6 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Carefusion 303, Inc.. Active years: 2023-2026.

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

6 out of 939

Carefusion 303, Inc.

patents

Years Active: 2023-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12548664 - Adaptive control of medical devices based on clinician interactions (2026-02-10),

2. 12458469 - Systems and methods for enforcing cleaning of a medical device (2025-11-04),

3. 12300373 - Patient care unit order confirmation (2025-05-13),

4. 11972851 - Patient care unit order confirmation (2024-04-30),

5. 11801117 - Systems and methods for enforcing cleaning of a medical device (2023-10-31),

6. 11783937 - Adaptive control of medical devices based on clinician interactions (2023-10-10),

Title: Innovations by Robert Regedanz in Patient Care Technology

Introduction

Robert Regedanz is an accomplished inventor based in San Diego, CA, with a focus on advancements in patient care technology. He holds a total of four patents, showcasing his commitment to improving healthcare delivery systems. His innovative work has significantly contributed to the efficiency and safety of medication administration in clinical settings.

Latest Patents

One of Regedanz's latest patents is centered around a patient care unit order confirmation system. This system provides a method for authorizing a user to operate a medication delivery device. The process includes retrieving a user history associated with the user, which contains dispensing records for pending medications. Based on this context, the system determines medication order candidates for present administration. It also presents a user interface for confirming a medication order and configures parameters of the medication delivery device based on the confirmed order.

Career Highlights

Regedanz is currently employed at CareFusion 303, Inc., where he continues to develop innovative solutions in the healthcare sector. His work has been instrumental in enhancing patient safety and streamlining medication delivery processes.

Collaborations

Throughout his career, Regedanz has collaborated with talented professionals, including Evan Chen and Lisa Diggett. These partnerships have fostered a creative environment that encourages the development of groundbreaking healthcare technologies.

Conclusion

Robert Regedanz's contributions to patient care technology through his patents and collaborations highlight his dedication to improving healthcare systems. His innovative solutions are paving the way for safer and more efficient medication administration in clinical environments.